The UK stock market has recently experienced fluctuations, with the FTSE 100 index closing lower due to weak trade data from China, highlighting concerns over global economic recovery. Despite these challenges, investors often find opportunities in lesser-known areas of the market. Penny stocks, although an outdated term, still represent smaller or newer companies that can offer significant value and potential growth for those willing to explore beyond the mainstream indices.

Name

Share Price

Market Cap

Financial Health Rating

Foresight Group Holdings (LSE:FSG)

£4.10

£467.57M

★★★★★★

Warpaint London (AIM:W7L)

£2.07

£167.23M

★★★★★★

On the Beach Group (LSE:OTB)

£2.15

£311.55M

★★★★★★

Ingenta (AIM:ING)

£0.875

£13.21M

★★★★★★

System1 Group (AIM:SYS1)

£2.04

£25.89M

★★★★★★

Integrated Diagnostics Holdings (LSE:IDHC)

$0.675

$392.4M

★★★★★☆

Impax Asset Management Group (AIM:IPX)

£1.486

£182.98M

★★★★★★

Spectra Systems (AIM:SPSY)

£1.435

£69.31M

★★★★★☆

M.T.I Wireless Edge (AIM:MWE)

£0.52

£44.82M

★★★★★★

Begbies Traynor Group (AIM:BEG)

£1.105

£176.36M

★★★★★★

Click here to see the full list of 306 stocks from our UK Penny Stocks screener.

Let’s review some notable picks from our screened stocks.

Simply Wall St Financial Health Rating: ★★★★★★

Overview: accesso Technology Group plc develops technology solutions for the attractions and leisure industry and has a market cap of £136.31 million.

Operations: The company generates revenue through three main segments: Ticketing ($114.34 million), Guest Experience ($28.66 million), and Professional Services ($8.00 million).

Market Cap: £136.31M

accesso Technology Group, with a market cap of £136.31 million, has shown resilience in the penny stock landscape through strategic advancements and financial management. The company recently enhanced its product offerings with AI-driven solutions like accesso Freedom and Scan & Go, aiming to improve guest experiences across attractions globally. Financially, accesso’s debt levels have decreased over five years while maintaining profitability growth at 19.9% last year, surpassing industry averages. Despite lowering its revenue guidance for 2025, the company continues to buy back shares and strengthen its board with experienced leaders like new CCO Mike Evenson.

AIM:ACSO Revenue & Expenses Breakdown as at Dec 2025

AIM:ACSO Revenue & Expenses Breakdown as at Dec 2025

Simply Wall St Financial Health Rating: ★★★★★★

Story Continues